EP 3793530 A1 20210324 - SOLID DISPERSION CONTAINING RITONAVIR
Title (en)
SOLID DISPERSION CONTAINING RITONAVIR
Title (de)
FESTE DISPERSION MIT RITONAVIR
Title (fr)
DISPERSION SOLIDE CONTENANT DU RITONAVIR
Publication
Application
Priority
- EP 18173268 A 20180518
- EP 2019062639 W 20190516
Abstract (en)
[origin: EP3569225A1] The present invention relates to a solid dispersion containing ritonavir and a cationic polymer, and to the use of the solid dispersion for the preparation of a pharmaceutical composition for oral administration, which is preferably a tablet. The pharmaceutical composition is intended for the treatment of HIV and may additionally contain a HIV protease inhibitor selected from darunavir, lopinavir, atazanavir, tipranavir and saquinavir.
IPC 8 full level
A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/24 (2006.01); A61K 31/427 (2006.01)
CPC (source: EP)
A61K 9/167 (2013.01); A61K 9/2027 (2013.01); A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 9/209 (2013.01); A61K 31/427 (2013.01); A61K 45/06 (2013.01)
Citation (search report)
See references of WO 2019219823A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
EP 3569225 A1 20191120; EP 3793530 A1 20210324; WO 2019219823 A1 20191121
DOCDB simple family (application)
EP 18173268 A 20180518; EP 19725121 A 20190516; EP 2019062639 W 20190516